Novel carboranyl-BODIPY conjugates: design, synthesis and anti-cancer activity.

A series of four carboranyl-BODIPY conjugates (-CB-10, -CB-15, Me--CB-28, and Me--CB-35) and one phenylene-BODIPY conjugate (PB-20) were synthesized. The carboranyl-BODIPY conjugates incorporate boron clusters, specifically - and -carboranes, covalently linked to BODIPY fluorophores while the phenylene-BODIPY conjugate features a phenylene ring covalently linked to BODIPY fluorophore. The newly synthesized conjugates were characterized by H NMR, C NMR, B NMR, F NMR, FT-IR, and high-resolution mass spectral analysis.

Preparation of dendritic carboranyl glycoconjugates as potential anticancer therapeutics.

A series of carborane-appended glycoconjugates containing three and six glucose and galactose moieties have been synthesized Cu(i)-catalyzed azide-alkyne [3 + 2] click cycloaddition reaction. The carboranyl glycoconjugates containing three glucose and galactose moieties were found to be partially water soluble whereas increasing the number to six made them completely water soluble. The evaluation of cytotoxicities and IC values of newly synthesized carboranyl glycoconjugates was carried out using two cancerous cell lines (MCF-7 breast cancer cells and A431 skin cancer cells) and one normal cell line (HaCaT skin epidermal cell line).